Major disruptive forces affecting the health care and life sciences industry are forging a new payer environment with value demonstration and pricing at its core; consequently, pharma and biotech companies are being forced to adapt and create new go-to-market strategies, whereby they are increasingly taking greater ownership of the patient pathwayand looking for “beyond the pill” solutions to improve overall health outcomes, while being rewarded for such endeavors.
Fortunately, health information technologies, sophisticated data management tools and digital health applications that are bringing a new level of transparency, immediacy, and precision to health outcomes-based approaches.
Thus, the information infrastructure is much more capable than ever before of supporting more multi-factorial — often outcomes and financial risk sharing-based— contracts with payers. This webinar, “Value-Based Contracting and Innovative Payer Engagement for Medical Affairs Professionals: Where is the Market Moving,” reveals developing trends in the U.S. and Europe and discusses the decision points that are important to manufacturers as they consider such approaches.
- Hear about current trends and anticipated innovations, including the use of outcomes-based agreements;
- Learn why traditional contracting may not be enough to address the needs of both payers and pharma manufacturers;
- Get insights on the key payer engagement issues you should be considering today to optimize the market success of your products; and
- Understand the key roles medical affairs professionals are playing in value based payer engagement.